Following intense negotiations, in March the House and Senate finally passed an appropriations package that funded the federal government for Fiscal Year (FY) 2022, which technically began October 1, 2021. The $1.5-trillion package received bipartisan support and follows months of advocacy by the Endocrine Society with increased funding for our priorities. The bill includes several important...
Endocrine Society Advocates for Increased Funding for NIH Research, CDC
In another political nailbiter, with less than 24 hours remaining before all federal government funding would expire and cause a government shut-down, the U.S. Senate cleared legislation last month to continue funding the federal government through March 11. The temporary spending bill is the third such short-term funding bill for fiscal year (FY) 2022, which...
Congress Approves Continuing Resolution to Fund NIH Through February 18
With just hours to spare before its December 3 deadline, Congress averted a government shutdown and passed a continuing resolution (CR) that will fund the government at the previous year’s level through February 18, 2022. We appreciate the Endocrine Society members who participated in our online campaign, which helped avoid a destabilizing shutdown and ensured...
Advocacy Victory: EU Effectively Bans BPA in Food Contact Materials
The European Food Safety Administration (EFSA) issued a draft opinion in December that lowers the ‘tolerable daily intake of BPA in food contact materials by six orders of magnitude – effectively a ban on BPA and an advocacy victory for the Endocrine Society. We have called for better regulation of endocrine-disrupting chemicals in food contact materials. The Endocrine Society will provide supporting comments to...
For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and... The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. Though our work in 2021 remained virtual, we successfully advocated for our policy priorities and raised the visibility of the value of endocrinology and endocrine research. Let’s look back at some of our wins from this year....
Failure to Reach Long-Term Budget Deal Disrupts Biomedical Research
Endocrine Society calls for $46.4 billion in NIH appropriations. Congress missed an opportunity to secure long-term funding for life-saving medical research in the midst of the pandemic. Congress averted a government shutdown by passing a two-month-long Continuing Resolution (CR), but it only provides temporary funding for the National Institutes of Health (NIH) and other government...
Endocrine Society Joins Rally for Medical Research Hill Day to Advocate for NIH Funding
On September 23, the Endocrine Society will join a group of scientific societies, academic institutions, and other biomedical research advocates as part of the 9th Annual Rally for Medical Research. Rally participants will call on the Congress to make funding for the National Institutes of Health (NIH) a national priority and raise awareness about the...
